Company Corline Biomedical AB

CLBIO

SE0006887451

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Company contact information

Sector

EPS Revisions

Annual profits - Rate of surprise

Sector Specialty & Advanced Pharmaceuticals

Market Closed - Nasdaq Stockholm Other stock markets 14:55:43 03/05/2024 BST			5-day change	1st Jan Change
10.45 ^SEK	-0.95%		+1.46%	-29.87%

04-30	Corline Biomedical AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
02-14	Corline Biomedical AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Corline Biomedical AB is a Sweden-based biotechnology company. It develops, manufactures and markets heparin-based solutions to improve kidney transplantation, cell therapies and applications in regenerative medicine.

Number of employees: 13

SEK in Million	2021	Weight	2022	Weight	Delta
Heparin Based Solutions 100.0 %	7	100.0 %	24	100.0 %	+233.47%

SEK in Million	2021	Weight	2022	Weight	Delta
Sweden 100.0 %	7	100.0 %	24	100.0 %	+233.47%

Managers	Title	Age	Since
Lars Henrik Nittmar CEO	Chief Executive Officer	58	31/12/07
Gunnar Tufveson CTO	Chief Tech/Sci/R&D Officer	-	31/12/17
Magnus Nilsson BRD	Director/Board Member	68	17/11/20
Åsa Holm LAW	General Counsel	-	31/12/20
Fredrik Carlsson PRN	Corporate Officer/Principal	-	31/12/10

Members of the board	Title	Age	Since
Magnus Nilsson BRD	Director/Board Member	68	17/11/20
Lars Fredrik Sunnanväder BRD	Director/Board Member	-	31/12/04
Lars Adam Holger Dahlberg CHM	Chairman	51	31/12/04
Gunilla Anders Ekström BRD	Director/Board Member	66	31/12/16
Henrik Krook BRD	Director/Board Member	51	31/12/17
Tomas Lifvendahl BRD	Director/Board Member	-	31/12/21

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	21,490,819	9,707,353 ( 45.17 %)	0	45.17 %

Corline Biomedical AB

Lefflersgatan 5

754 50, Uppsala

+46 18 71 30 90

http://www.corline.com

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Specialty & Advanced Pharmaceuticals

	1st Jan change	Capi.
CORLINE BIOMEDICAL AB	-29.87%	20.79M
MERCK KGAA	+5.48%	71.19B
KYOWA KIRIN CO. LTD.	+12.55%	9.3B
SK BIOPHARMACEUTICALS CO., LTD.	-13.75%	5.01B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+42.38%	4.47B
YUHAN CORPORATION	+4.51%	3.96B
INDIVIOR PLC	+21.10%	2.44B
BETTA PHARMACEUTICALS CO., LTD.	-19.05%	2.41B
CHANGCHUN BCHT BIOTECHNOLOGY CO.	-28.72%	2.23B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	+11.13%	2.02B

Specialty & Advanced Pharmaceuticals